Ex-FDA Official Says DePuy Followed Hip Implant Watch Rules

Law360, Chicago (April 4, 2013, 4:12 PM EDT) -- During trial Thursday over Johnson & Johnson subsidiary DePuy Inc.'s ASR XL metal hip, a former U.S. Food and Drug Administration compliance official testified that he believed the company's post-market surveillance for the device substantially complied with federal laws and regulations.

Timothy Ulatowski, a former director of the Office of Compliance within the FDA's Center for Devices and Radiological Health, also testified in Illinois under questioning by a DePuy attorney that the health hazard evaluations DePuy conducted for its ASR XL were "very thorough" and "adequately...
To view the full article, register now.